Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo

By A. Rimoin, Prime M. Mulembakani, S. Johnston, James O Lloyd Smith, Neville K Kisalu, T. Kinkela, S. Blumberg, H. Thomassen, B. Pike, Joseph N. Fair and 9 more. Proceedings of the National Academy of Sciences of the United States of America, 2010

765 citations recorded by the source corpus.

Subfields: Epidemiology, Molecular Biology, Virology

View Paper: https://www.semanticscholar.org/paper/8d5feccbe5c51b66758a6d03dda679835a018ed8

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Yinka-Ogunleye
2. E. Bunge
3. O. Aruna
4. A. McCollum
5. M. Dalhat
6. D. Ogoina
7. B. Hoet
8. I. Damon

Citations in the corpus

• Human Monkeypox (2013, background): “lack of vaccination in these populations may contribute to an increased incidence of infection [31].”
• The changing epidemiology of human monkeypox—A potential threat? A systematic review (2021, background): “The number of cases presented in the maps in this review, especially after 1986 when WHO stopped their surveillance program in the DRC, are likely lower than the actual number of cases [28] and underreporting is quite probable, despite implementation of the Integrated Disease Surveillance and Respon”
• Outbreak of human monkeypox in Nigeria in 2017–18: a clinical and epidemiological report (2019, background): “8,25,26 Human monkeypox is known to be endemic in Africa, mainly in rainforest areas, and most outbreaks in endemic countries are reported in rural communities.”